Clinical trial
Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China…
NCT00478790 · Pro Top & Mediking Company Limited, Industry · Unknown status
Key facts
| NCT number | NCT00478790 |
|---|---|
| Title | Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital |
| Official title | Study of the Safety and Effectiveness of the Ologen(OculusGen) Collagen Matrix Implant as an Aid in Glaucoma and Pterygium Surgery |
| Lead sponsor | Pro Top & Mediking Company Limited, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glaucomas, Pterygium |
| Intervention type | Device |
| Interventions | ologen™ Collagen matrix implantation in glaucoma filtering surgery |
| Enrollment | 60 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | May 25, 2007 |
| Last update posted | Oct 7, 2011 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: